Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Frederick Hayden
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Disorders
Procedures
Anatomy
Sign-in to see full Profile
Network (preview)
18
Gubareva, Larisa
15
Arruda, Eurico
13
Gwaltney, Jack
12
Winther, Birgit
11
Hendley, Owen
11
Kaiser, Laurent
9
Ison, Michael
9
Doyle, William
9
Treanor, John
6
Webster, Robert
6
Zambon, Maria
6
Mishin, Vasiliy
6
Ward, Penelope
5
Pitkäranta, A
5
Platts-Mills, Thomas
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Frederick Hayden (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Peterson Kristine M; O'Shea Marianne; Stam Wiro; Mohede Inge C M; Patrie James T; Hayden Frederick G
Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness.
Antiviral therapy 2009;14(1):33-43.
-
2008: Falsey Ann R; Walsh Edward E; Capellan Jose; Gravenstein Stefan; Zambon Maria; Yau Eddy; Gorse Geoffrey J; Edelman Robert; Hayden Frederick G; McElhaney Janet E; Neuzil Kathleen M; Nichol Kristen L; Simões Eric A F; Wright Peter F; Sales Valérie M-P
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals.
The Journal of infectious diseases 2008;198(9):1317-26.
-
2008: Higgs Elizabeth S; Hayden Frederick G; Chotpitayasunondh Tawee; Whitworth Jimmy; Farrar Jeremy
The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor.
Antiviral research 2008;78(1):64-8.
-
2008: Pappas Diane E; Hendley J Owen; Hayden Frederick G; Winther Birgit
Symptom profile of common colds in school-aged children.
The Pediatric infectious disease journal 2008;27(1):8-11.
-
2007: Winther Birgit; Hayden Frederick G; Hendley J Owen
Middle ear pressure in preschool age children: influence of respiratory illness, season, and picornavirus or bacteria in the nasopharynx.
Acta oto-laryngologica 2007;127(8):796-800.
-
2007: Treanor John J; Schiff Gilbert M; Hayden Frederick G; Brady Rebecca C; Hay C Mhorag; Meyer Anthony L; Holden-Wiltse Jeanne; Liang Hua; Gilbert Adam; Cox Manon
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2007;297(14):1577-82.
-
2007: Bermingham Alison; Henrickson Kelly; Hayden Frederick; Zambon Maria
VII International Symposium on Respiratory Viral Infections.
Antiviral therapy 2007;12(4 Pt B):671-93.
-
2006: Hayden Frederick G; Pavia Andrew T
Antiviral management of seasonal and pandemic influenza.
The Journal of infectious diseases 2006;194 Suppl 2():S119-26.
-
2006: Hayden Frederick G
Antivirals for influenza: historical perspectives and lessons learned.
Antiviral research 2006;71(2-3):372-8.
-
2006: Mishin Vasiliy P; Hayden Frederick G; Signorelli Kathy L; Gubareva Larisa V
Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.
Antiviral research 2006;71(1):64-8.
-
2006: Monto Arnold S; McKimm-Breschkin Jennifer L; Macken Catherine; Hampson Alan W; Hay Alan; Klimov Alexander; Tashiro Masato; Webster Robert G; Aymard Michelle; Hayden Frederick G; Zambon Maria
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.
Antimicrobial agents and chemotherapy 2006;50(7):2395-402.
-
2006: Winther Birgit; Hayden Frederick G; Hendley J Owen
Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season.
Journal of medical virology 2006;78(5):644-50.
-
2006: Malakhov Michael P; Aschenbrenner Laura M; Smee Donald F; Wandersee Miles K; Sidwell Robert W; Gubareva Larisa V; Mishin Vasiliy P; Hayden Frederick G; Kim Do Hyong; Ing Alice; Campbell Erin R; Yu Mang; Fang Fang
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.
Antimicrobial agents and chemotherapy 2006;50(4):1470-9.
-
2006: Hayden Frederick G
Respiratory viral threats.
Current opinion in infectious diseases 2006;19(2):169-78.
-
2006: Ison Michael G; Mishin Vasiliy P; Braciale Thomas J; Hayden Frederick G; Gubareva Larisa V
Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection.
The Journal of infectious diseases 2006;193(6):765-72.
-
2006: Ison Michael G; Gubareva Larisa V; Atmar Robert L; Treanor John; Hayden Frederick G
Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.
The Journal of infectious diseases 2006;193(6):760-4.
-
2006: Hayden Frederick G
Antiviral resistance in influenza viruses--implications for management and pandemic response.
The New England journal of medicine 2006;354(8):785-8.
-
2005: Mishin Vasiliy P; Hayden Frederick G; Gubareva Larisa V
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.
Antimicrobial agents and chemotherapy 2005;49(11):4515-20.
-
2005: Pevear Daniel C; Hayden Frederick G; Demenczuk Tina M; Barone Linda R; McKinlay Mark A; Collett Marc S
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses.
Antimicrobial agents and chemotherapy 2005;49(11):4492-9.
-
2005: Mishin Vasiliy P; Novikov Dmitri; Hayden Frederick G; Gubareva Larisa V
Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
Journal of virology 2005;79(19):12416-24.
-
2005: Mishin Vasiliy P; Nedyalkova Marina S; Hayden Frederick G; Gubareva Larisa V
Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model.
Vaccine 2005;23(22):2922-7.
-
2005: Hendley J Owen; Hayden Frederick G; Winther Birgit
Weekly point prevalence of Streptococcus pneumoniae, Hemophilus influenzae and Moraxella catarrhalis in the upper airways of normal young children: effect of respiratory illness and season.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(3):213-20.
-
2005: Ison Michael G; Campbell Vicky; Rembold Chris; Dent John; Hayden Frederick G
Cardiac findings during uncomplicated acute influenza in ambulatory adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(3):415-22.
-
2005: Barroso Luis; Treanor John; Gubareva Larisa; Hayden Frederick G
Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
Antiviral therapy 2005;10(8):901-10.
-
2005: Hayden Frederick; Klimov Alexander; Tashiro Masato; Hay Alan; Monto Amold; McKimm-Breschkin Jennifer; Macken Catherine; Hampson Alan; Webster Robert G; Amyard Michèle; Zambon Maria
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.
Antiviral therapy 2005;10(8):873-7.
-
2004: Hayden Frederick G
Pandemic influenza: is an antiviral response realistic?
The Pediatric infectious disease journal 2004;23(11 Suppl):S262-9.
-
2004: Salgado Cassandra D; Giannetta Eve T; Hayden Frederick G; Farr Barry M
Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(11):923-8.
-
2004: Heymann Peter W; Carper Holliday T; Murphy Deborah D; Platts-Mills Thomas A E; Patrie James; McLaughlin Anne P; Erwin Elizabeth A; Shaker Marcus S; Hellems Martha; Peerzada Jehanna; Hayden Frederick G; Hatley Tina K; Chamberlain Rachel
Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing.
The Journal of allergy and clinical immunology 2004;114(2):239-47.
-
2004: Ison Michael G; Johnston Sebastian L; Openshaw Peter; Murphy Brian; Hayden Frederick
Current research on respiratory viral infections: Fifth International Symposium.
Antiviral research 2004;62(3):75-110.
-
2004: Hayden Frederick G; Belshe Robert; Villanueva Catalina; Lanno Riin; Hughes Claire; Small Ian; Dutkowski Regina; Ward Penelope; Carr Jackie
Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
The Journal of infectious diseases 2004;189(3):440-9.
-
2004: Hayden Frederick G
Rhinovirus and the lower respiratory tract.
Reviews in medical virology 2004;14(1):17-31.
-
2003: Hayden Frederick G; Turner Ronald B; Gwaltney Jack M; Chi-Burris Kathy; Gersten Merril; Hsyu Poe; Patick Amy K; Smith George J; Zalman Leora S
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
Antimicrobial agents and chemotherapy 2003;47(12):3907-16.
-
2003: Chi David H; Hendley J Owen; French Pamela; Arango Pablo; Hayden Frederick G; Winther Birgit
Nasopharyngeal reservoir of bacterial otitis media and sinusitis pathogens in adults during wellness and viral respiratory illness.
American journal of rhinology 2003;17(4):209-14.
-
2003: McKimm-Breschkin J; Trivedi T; Hampson A; Hay A; Klimov A; Tashiro M; Hayden F; Zambon M
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.
Antimicrobial agents and chemotherapy 2003;47(7):2264-72.
-
2003: Ison Michael G; Gnann John W; Nagy-Agren Stephanie; Treannor John; Paya Carlos; Steigbigel Roy; Elliott Michael; Weiss Heidi L; Hayden Frederick G;
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
Antiviral therapy 2003;8(3):183-90.
-
2003: Hayden Frederick G; Herrington Darrell T; Coats Teresa L; Kim Kenneth; Cooper Ellen C; Villano Stephen A; Liu Siyu; Hudson Spencer; Pevear Daniel C; Collett Marc; McKinlay Mark;
Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(12):1523-32.
-
2003: Zambrano Juan C; Carper Holliday T; Rakes Gary P; Patrie James; Murphy Deborah D; Platts-Mills Thomas A E; Hayden Frederick G; Gwaltney Jack M; Hatley Tina K; Owens Angela M; Heymann Peter W
Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE.
The Journal of allergy and clinical immunology 2003;111(5):1008-16.
-
2003: Ison Michael G; Hayden Frederick G; Kaiser Laurent; Corey Lawrence; Boeckh Michael
Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(9):1139-43.
-
2003: Wetherall N T; Trivedi T; Zeller J; Hodges-Savola C; McKimm-Breschkin J L; Zambon M; Hayden F G
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.
Journal of clinical microbiology 2003;41(2):742-50.
-
2002: Gubareva Larisa V; Novikov Dmitri V; Hayden Frederick G
Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families.
The Journal of infectious diseases 2002;186(11):1575-81.
-
2002: Gubareva Larisa V; Nedyalkova Marina S; Novikov Dmitri V; Murti K Gopal; Hoffmann Erich; Hayden Frederick G
A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site.
The Journal of general virology 2002;83(Pt 11):2683-92.
-
2002: Ison Michael G; Hayden Frederick G
Viral infections in immunocompromised patients: what's new with respiratory viruses?
Current opinion in infectious diseases 2002;15(4):355-67.
-
2002: Ison Michael G; Mills John; Openshaw Peter; Zambon Maria; Osterhaus Albert; Hayden Frederick
Current research on respiratory viral infections: Fourth International Symposium.
Antiviral research 2002;55(2):227-78.
-
2002: Winther Birgit; Hayden Frederick G; Arruda Eurico; Dutkowski Regina; Ward Penelope; Hendley J Owen
Viral respiratory infection in schoolchildren: effects on middle ear pressure.
Pediatrics 2002;109(5):826-32.
-
2002: Kati Warren M; Montgomery Debra; Carrick Robert; Gubareva Larisa; Maring Clarence; McDaniel Keith; Steffy Kevin; Molla Akhteruzzaman; Hayden Frederick; Kempf Dale; Kohlbrenner William
In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
Antimicrobial agents and chemotherapy 2002;46(4):1014-21.
-
2002: Hayden Frederick G; Coats Teresa; Kim Kenneth; Hassman Howard A; Blatter Mark M; Zhang Bing; Liu Siyu
Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.
Antiviral therapy 2002;7(1):53-65.
-
2002: Salgado Cassandra D; Farr Barry M; Hall Keri K; Hayden Frederick G
Influenza in the acute hospital setting.
The Lancet infectious diseases 2002;2(3):145-55.
-
2002: Nedyalkova Marina S; Hayden Frederick G; Webster Robert G; Gubareva Larisa V
Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA.
The Journal of infectious diseases 2002;185(5):591-8.
-
2002: Winther Birgit; Arruda Eurico; Witek Theodore J; Marlin Steven D; Tsianco Michael M; Innes Donald J; Hayden Frederick G
Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection.
Archives of otolaryngology--head & neck surgery 2002;128(2):131-6.
-
2002: Gubareva Larisa V; Webster Robert G; Hayden Frederick G
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.
Antiviral research 2002;53(1):47-61.
-
2001: Hayden F G
Perspectives on antiviral use during pandemic influenza.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2001;356(1416):1877-84.
-
2001: Gubareva L V; Webster R G; Hayden F G
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
Antimicrobial agents and chemotherapy 2001;45(12):3403-8.
-
2001: Ison M G; Hayden F G
Therapeutic options for the management of influenza.
Current opinion in pharmacology 2001;1(5):482-90.
-
2001: Kaiser L; Fritz R S; Straus S E; Gubareva L; Hayden F G
Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.
Journal of medical virology 2001;64(3):262-8.
-
2001: Schmidt A C; Couch R B; Galasso G J; Hayden F G; Mills J; Murphy B R; Chanock R M
Current research on respiratory viral infections: Third International Symposium.
Antiviral research 2001;50(3):157-96.
-
2001: Malcolm E; Arruda E; Hayden F G; Kaiser L
Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;21(1):9-16.
-
2001: Gubareva L V; Kaiser L; Matrosovich M N; Soo-Hoo Y; Hayden F G
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.
The Journal of infectious diseases 2001;183(4):523-31.
-
2000: Hayden F G
Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention.
Vaccine 2000;19 Suppl 1():S66-70.
-
2000: Kaiser L; Keene O N; Hammond J M; Elliott M; Hayden F G
Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.
Archives of internal medicine 2000;160(21):3234-40.
-
2000: Hayden F G; Gubareva L V; Monto A S; Klein T C; Elliot M J; Hammond J M; Sharp S J; Ossi M J;
Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
The New England journal of medicine 2000;343(18):1282-9.
-
2000: Hayden F G; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
Oral oseltamivir in human experimental influenza B infection.
Antiviral therapy 2000;5(3):205-13.
-
2000: Kaiser L; Crump C E; Hayden F G
In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
Antiviral research 2000;47(3):215-20.
-
2000: Munoz F M; Galasso G J; Gwaltney J M; Hayden F G; Murphy B; Webster R; Wright P; Couch R B
Current research on influenza and other respiratory viruses: II international symposium.
Antiviral research 2000;46(2):91-124.
-
2000: Kaiser L; Henry D; Flack N P; Keene O; Hayden F G
Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(3):587-9.
-
2000: Gubareva L V; Kaiser L; Hayden F G
Influenza virus neuraminidase inhibitors.
Lancet 2000;355(9206):827-35.
-
2000: Treanor J J; Hayden F G; Vrooman P S; Barbarash R; Bettis R; Riff D; Singh S; Kinnersley N; Ward P; Mills R G
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
JAMA : the journal of the American Medical Association 2000;283(8):1016-24.
-
1999: Kaiser L; Briones M S; Hayden F G
Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 1999;14(3):191-7.
-
1999: Hayden F G; Atmar R L; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills R G
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
The New England journal of medicine 1999;341(18):1336-43.
-
1999: Hayden F G; Treanor J J; Fritz R S; Lobo M; Betts R F; Miller M; Kinnersley N; Mills R G; Ward P; Straus S E
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
JAMA : the journal of the American Medical Association 1999;282(13):1240-6.
-
1999: Fritz R S; Hayden F G; Calfee D P; Cass L M; Peng A W; Alvord W G; Strober W; Straus S E
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment.
The Journal of infectious diseases 1999;180(3):586-93.
-
1999: Kaiser L; Couch R B; Galasso G J; Glezen W P; Webster R G; Wright P F; Hayden F G
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998.
Antiviral research 1999;42(3):149-75.
-
1999: Calfee D P; Peng A W; Cass L M; Lobo M; Hayden F G
Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.
Antimicrobial agents and chemotherapy 1999;43(7):1616-20.
-
1999: Turner R B; Wecker M T; Pohl G; Witek T J; McNally E; St George R; Winther B; Hayden F G
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
JAMA : the journal of the American Medical Association 1999;281(19):1797-804.
-
1999: Rakes G P; Arruda E; Ingram J M; Hoover G E; Zambrano J C; Hayden F G; Platts-Mills T A; Heymann P W
Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses.
American journal of respiratory and critical care medicine 1999;159(3):785-90.
-
1999: Calfee D P; Peng A W; Hussey E K; Lobo M; Hayden F G
Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
Antiviral therapy 1999;4(3):143-9.
-
1999: Hayden F G
Update on influenza and rhinovirus infections.
Advances in experimental medicine and biology 1999;458():55-67.
-
1999: Kaiser L; Hayden F G
Hospitalizing influenza in adults.
Current clinical topics in infectious diseases 1999;19():112-34.
-
1998: Calfee D P; Hayden F G
New approaches to influenza chemotherapy. Neuraminidase inhibitors.
Drugs 1998;56(4):537-53.
-
1998: Pitkäranta A; Jero J; Arruda E; Virolainen A; Hayden F G
Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion.
The Journal of pediatrics 1998;133(3):390-4.
-
1998: Murphy A W; Platts-Mills T A; Lobo M; Hayden F
Respiratory nitric oxide levels in experimental human influenza.
Chest 1998;114(2):452-6.
-
1998: Pitkäranta A; Virolainen A; Jero J; Arruda E; Hayden F G
Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction.
Pediatrics 1998;102(2 Pt 1):291-5.
-
1998: Pitkäranta A; Wecker M T; Korts D C; Hayden F G
Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.
American journal of rhinology 1998;12(2):125-9.
-
1998: Hayden F G; Fritz R; Lobo M C; Alvord W; Strober W; Straus S E
Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.
The Journal of clinical investigation 1998;101(3):643-9.
-
1997: Walker J B; Hussey E K; Treanor J J; Montalvo A; Hayden F G
Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza.
The Journal of infectious diseases 1997;176(6):1417-22.
-
1997: Arruda E; Pitkäranta A; Witek T J; Doyle C A; Hayden F G
Frequency and natural history of rhinovirus infections in adults during autumn.
Journal of clinical microbiology 1997;35(11):2864-8.
-
1997: Hayden F G; Osterhaus A D; Treanor J J; Fleming D M; Aoki F Y; Nicholson K G; Bohnen A M; Hirst H M; Keene O; Wightman K
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
The New England journal of medicine 1997;337(13):874-80.
-
1997: Hayden F G
Antivirals for pandemic influenza.
The Journal of infectious diseases 1997;176 Suppl 1():S56-61.
-
1997: Pitkäranta A; Arruda E; Malmberg H; Hayden F G
Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.
Journal of clinical microbiology 1997;35(7):1791-3.
-
1997: Hayden F G
Prevention and treatment of influenza in immunocompromised patients.
The American journal of medicine 1997;102(3A):55-60; discussion 75-6.
-
1997: Turner J C; Hayden F G; Lobo M C; Ramirez C E; Murren D
Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students.
Journal of clinical microbiology 1997;35(1):1-4.
-
1996: Adal K A; Flowers R H; Anglim A M; Hayden F G; Titus M G; Coyner B J; Farr B M
Prevention of nosocomial influenza.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1996;17(10):641-8.
-
1996: Hayden F G; Diamond L; Wood P B; Korts D C; Wecker M T
Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.
Annals of internal medicine 1996;125(2):89-97.
-
1996: Arruda E; Crump C E; Rollins B S; Ohlin A; Hayden F G
Comparative susceptibilities of human embryonic fibroblasts and HeLa cells for isolation of human rhinoviruses.
Journal of clinical microbiology 1996;34(5):1277-9.
-
1996: Gustafson L M; Proud D; Hendley J O; Hayden F G; Gwaltney J M
Oral prednisone therapy in experimental rhinovirus infections.
The Journal of allergy and clinical immunology 1996;97(4):1009-14.
-
1996: Doyle W J; Skoner D P; White M; Hayden F; Kaplan A P; Kaliner M A; Shibayama Y; Fireman P
Pattern of nasal secretions during experimental influenza virus infection.
Rhinology 1996;34(1):2-8.
-
1996: Hayden F G; Sable C A; Connor J D; Lane J
Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection.
Antiviral therapy 1996;1(1):51-6.
-
1996: Hayden F G
Combination antiviral therapy for respiratory virus infections.
Antiviral research 1996;29(1):45-8.
-
1996: Hayden F G; Treanor J J; Betts R F; Lobo M; Esinhart J D; Hussey E K
Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
JAMA : the journal of the American Medical Association 1996;275(4):295-9.
-
1996: Arruda E; Hayden F G
Update on therapy of influenza and rhinovirus infections.
Advances in experimental medicine and biology 1996;394():175-87.
-
1995: Sable C A; Hayden F G
Orthomyxoviral and paramyxoviral infections in transplant patients.
Infectious disease clinics of North America 1995;9(4):987-1003.
-
1995: Buchman C A; Doyle W J; Skoner D P; Post J C; Alper C M; Seroky J T; Anderson K; Preston R A; Hayden F G; Fireman P
Influenza A virus--induced acute otitis media.
The Journal of infectious diseases 1995;172(5):1348-51.
-
1995: Arruda E; Boyle T R; Winther B; Pevear D C; Gwaltney J M; Hayden F G
Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization.
The Journal of infectious diseases 1995;171(5):1329-33.
-
1995: Buchman C A; Swarts J D; Seroky J T; Panagiotou N; Hayden F; Doyle W J
Otologic and systemic manifestations of experimental influenza A virus infection in the ferret.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1995;112(4):572-8.
-
1995: Hayden F G; Hipskind G J; Woerner D H; Eisen G F; Janssens M; Janssen P A; Andries K
Intranasal pirodavir (R77,975) treatment of rhinovirus colds.
Antimicrobial agents and chemotherapy 1995;39(2):290-4.
-
1994: Hayden F G; Rollins B S; Madren L K
Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium.
Antiviral research 1994;25(2):123-31.
-
1994: Hayden F G; Himel H N; Heggers J P
Herpesvirus infections in burn patients.
Chest 1994;106(1 Suppl):15S-21S; discussion 34S-35S.
-
1994: Crump C E; Arruda E; Hayden F G
Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule.
Antimicrobial agents and chemotherapy 1994;38(6):1425-7.
-
1994: Hayden F G; Tunkel A R; Treanor J J; Betts R F; Allerheiligen S; Harris J
Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans.
Antimicrobial agents and chemotherapy 1994;38(5):1178-81.
-
1994: Doyle W J; Skoner D P; Hayden F; Buchman C A; Seroky J T; Fireman P
Nasal and otologic effects of experimental influenza A virus infection.
The Annals of otology, rhinology, and laryngology 1994;103(1):59-69.
-
1994: Arruda E; Crump C E; Hayden F G
In vitro selection of human rhinovirus relatively resistant to soluble intercellular adhesion molecule-1.
Antimicrobial agents and chemotherapy 1994;38(1):66-70.
-
1993: Duff A L; Pomeranz E S; Gelber L E; Price G W; Farris H; Hayden F G; Platts-Mills T A; Heymann P W
Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens.
Pediatrics 1993;92(4):535-40.
-
1993: Arruda E; Hayden F G
Detection of human rhinovirus RNA in nasal washings by PCR.
Molecular and cellular probes 1993;7(5):373-9.
-
1993: Rollins B S; Elkhatieb A H; Hayden F G
Comparative anti-influenza virus activity of 2'-deoxy-2'-fluororibosides in vitro.
Antiviral research 1993;21(4):357-68.
-
1993: Doyle W J; Riker D K; McBride T P; Hayden F G; Hendley J O; Swarts J D; Gwaltney J M
Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus colds.
The Annals of otology, rhinology, and laryngology 1993;102(7):521-7.
-
1993: Jernigan J A; Lowry B S; Hayden F G; Kyger S A; Conway B P; Gröschel D H; Farr B M
Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control.
The Journal of infectious diseases 1993;167(6):1307-13.
-
1993: Turner R B; Dutko F J; Goldstein N H; Lockwood G; Hayden F G
Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.
Antimicrobial agents and chemotherapy 1993;37(2):297-300.
-
1992: Turner B W; Cail W S; Hendley J O; Hayden F G; Doyle W J; Sorrentino J V; Gwaltney J M
Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus colds.
The Journal of allergy and clinical immunology 1992;90(3 Pt 2):474-8.
-
1992: Sperber S J; Doyle W J; McBride T P; Sorrentino J V; Riker D K; Hayden F G
Otologic effects of interferon beta serine in experimental rhinovirus colds.
Archives of otolaryngology--head & neck surgery 1992;118(9):933-6.
-
1992: Sperber S J; Hendley J O; Hayden F G; Riker D K; Sorrentino J V; Gwaltney J M
Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.
Annals of internal medicine 1992;117(1):37-41.
-
1992: Arruda E; Crump C E; Marlin S D; Merluzzi V J; Hayden F G
In vitro studies of the antirhinovirus activity of soluble intercellular adhesion molecule-1.
Antimicrobial agents and chemotherapy 1992;36(6):1186-91.
-
1992: Hayden F G; Andries K; Janssen P A
Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.
Antimicrobial agents and chemotherapy 1992;36(4):727-32.
-
1992: Sperber S J; Smith B V; Hayden F G
Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine.
Antiviral research 1992;17(3):213-22.
-
1992: Hayden F G; Hay A J
Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine.
Current topics in microbiology and immunology 1992;176():119-30.
-
1992: Gwaltney J M; Hendley O; Hayden F G; McIntosh K; Hollinger F B; Melnick J L; Turner R B
Updated recommendations for safety-testing of viral inocula used in volunteer experiments on rhinovirus colds.
Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progrès en virologie médicale 1992;39():256-63.
-
1991: Hayden F G; Sperber S J; Belshe R B; Clover R D; Hay A J; Pyke S
Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.
Antimicrobial agents and chemotherapy 1991;35(9):1741-7.
-
1991: de Arruda E; Mifflin T E; Gwaltney J M; Winther B; Hayden F G
Localization of rhinovirus replication in vitro with in situ hybridization.
Journal of medical virology 1991;34(1):38-44.
-
1990: Farr B M; Gwaltney J M; Hendley J O; Hayden F G; Naclerio R M; McBride T; Doyle W J; Sorrentino J V; Riker D K; Proud D
A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection.
The Journal of infectious diseases 1990;162(5):1173-7.
-
1990: Hayden F G; Rollins B S; Hay A J
Anti-influenza virus activity of the compound LY253963.
Antiviral research 1990;14(1):25-38.
-
1989: Hayden F G; Belshe R B; Clover R D; Hay A J; Oakes M G; Soo W
Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.
The New England journal of medicine 1989;321(25):1696-702.
-
1989: Sperber S J; Hayden F G
Protective effect of rhinovirus receptor blocking antibody in human fibroblast cells.
Antiviral research 1989;12(5-6):231-8.
-
1989: Sperber S J; Levine P A; Sorrentino J V; Riker D K; Hayden F G
Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
The Journal of infectious diseases 1989;160(4):700-5.
-
1989: McBride T P; Doyle W J; Hayden F G; Gwaltney J M
Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection.
Archives of otolaryngology--head & neck surgery 1989;115(9):1054-9.
-
1989: Sperber S J; Hayden F G
Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta.
Journal of interferon research 1989;9(3):285-93.
-
1989: Sperber S J; Sorrentino J V; Riker D K; Hayden F G
Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.
Bulletin of the New York Academy of Medicine 1989;65(1):145-60.
-
1988: Tominack R L; Wills R J; Gustavson L E; Hayden F G
Multiple-dose pharmacokinetics of rimantadine in elderly adults.
Antimicrobial agents and chemotherapy 1988;32(12):1813-9.
-
1988: Hayden F G; Innes D J; Mills S E; Levine P A
Intranasal tolerance and histopathologic effects of a novel synthetic interferon, rIFN-alpha Con1.
Antiviral research 1988;10(4-5):225-34.
-
1988: Gaffey M J; Hayden F G; Boyd J C; Gwaltney J M
Ipratropium bromide treatment of experimental rhinovirus infection.
Antimicrobial agents and chemotherapy 1988;32(11):1644-7.
-
1988: Herold D A; Anonick P K; Kinter M; Hayden F G
Measurement of rimantadine in plasma by capillary gas chromatography/mass spectrometry with a deuterium-labeled internal standard.
Clinical chemistry 1988;34(8):1597-9.
-
1988: Hayden F G; Gwaltney J M; Colonno R J
Modification of experimental rhinovirus colds by receptor blockade.
Antiviral research 1988;9(4):233-47.
-
1988: Sperber S J; Levine P A; Innes D J; Mills S E; Hayden F G
Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
The Journal of infectious diseases 1988;158(1):166-75.
-
1988: Sperber S J; Hayden F G
Chemotherapy of rhinovirus colds.
Antimicrobial agents and chemotherapy 1988;32(4):409-19.
-
1988: Gaffey M J; Kaiser D L; Hayden F G
Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms.
The Pediatric infectious disease journal 1988;7(3):223-8.
-
1988: VanLandingham K E; Marsteller H B; Ross G W; Hayden F G
Relapse of herpes simplex encephalitis after conventional acyclovir therapy.
JAMA : the journal of the American Medical Association 1988;259(7):1051-3.
-
1988: Hayden F G; Kaiser D L; Albrecht J K
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
Antimicrobial agents and chemotherapy 1988;32(2):224-30.
-
1987: Sperber S J; Hayden F G
Antiviral chemotherapy and prophylaxis of viral respiratory disease.
Clinics in laboratory medicine 1987;7(4):869-96.
-
1987: Hayden F G; Mills S E; Innes D J; Darragh A; Just M; Linder-Chiccolunghi S N; Gauci L
Tolerance and nasal histopathologic effects of long-term, low-dose intranasal recombinant interferon alpha-2A (Roferon-A).
Antiviral research 1987;8(3):139-49.
-
1987: Mifflin T E; Bowden J; Lovell M A; Bruns D E; Hayden F G; Gröschel D H; Savory J
Comparison of radioactive (32P and 35S) and biotinylated probes for detection of cytomegalovirus DNA.
Clinical biochemistry 1987;20(4):231-5.
-
1987: Hayden F G; Winther B; Donowitz G R; Mills S E; Innes D J
Human nasal mucosal responses to topically applied recombinant leukocyte A interferon.
The Journal of infectious diseases 1987;156(1):64-72.
-
1987: Tominack R L; Hayden F G
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.
Infectious disease clinics of North America 1987;1(2):459-78.
-
1987: Winther B; Innes D J; Mills S E; Mygind N; Zito D; Hayden F G
Lymphocyte subsets in normal airway mucosa of the human nose.
Archives of otolaryngology--head & neck surgery 1987;113(1):59-62.
Sign-in to see more
